Being able to rapidly reprogram Angry Kitten pods remotely based on the real-time threat environment would be hugely valuable ...

“One of the major advantages of Creative Biolabs,” the lead scientist explained during the interview, “is the versatility of ...

Ferrocene-modified covalent organic frameworks combine sonodynamic therapy with immune activation to suppress primary breast ...

Scientists have discovered a way to supercharge the immune system’s T cells by blocking a protein called Ant2, forcing the cells to rewire how they generate energy. This shift makes them more powerful ...

Medical oncologist (ex AstraZeneca, MorphoSys, Autolus Therapeutics) joins to advance Asgard’s lead asset AT-108 into Phase 1 ...

Some jellyfish possess the extraordinary ability to revert their cells back to an earlier developmental stage, effectively ...

Medical oncologist (ex AstraZeneca, MorphoSys, Autolus Therapeutics) joins to advance Asgard’s lead asset AT-108 into Phase 1 clinical developmentAT-108 is a transformative immunotherapy that triggers ...

A burgeoning field is launching its first clinical trial to find out whether dialing back cell development can safely refresh ...

A new technical paper, “Neural Computers,” was published by researchers at Meta AI and KAUST. Abstract “We propose a new ...

Scientists at Life Biosciences are preparing to begin testing partial reprogramming in people. It will mark the first time ...

Fibrosis, a characteristic of all chronic kidney diseases (CKD), is now recognized to be an independent predictor of disease ...

Researchers at Oregon Health & Science University have uncovered a key reason why immunotherapy has largely failed in ...